On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.
Saved in:
| Title: | On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. |
|---|---|
| Authors: | Hou LQ; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Liu JR; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Gu JL; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Chen ML; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Kuang LF; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Huang BH; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Zou WY; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Li J; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jan 17; Vol. 13, pp. 1306367. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38298443 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hou+LQ%22">Hou LQ</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+JR%22">Liu JR</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Gu+JL%22">Gu JL</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+ML%22">Chen ML</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Kuang+LF%22">Kuang LF</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Huang+BH%22">Huang BH</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zou+WY%22">Zou WY</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Jan 17; Vol. 13, pp. 1306367. <i>Date of Electronic Publication: </i>2024 Jan 17 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38298443 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2023.1306367 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1306367 Titles: – TitleFull: On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hou LQ – PersonEntity: Name: NameFull: Liu JR – PersonEntity: Name: NameFull: Gu JL – PersonEntity: Name: NameFull: Chen ML – PersonEntity: Name: NameFull: Kuang LF – PersonEntity: Name: NameFull: Huang BH – PersonEntity: Name: NameFull: Zou WY – PersonEntity: Name: NameFull: Li J IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 01 Text: 2024 Jan 17 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
